Drug shortages

Metformin Hydrochloride Tablet, Extended Release

Mylan Pharmaceuticals Inc., a Viatris Company

To Be Discontinued0378-6002-91Endocrinology/Metabolism
Open FDA's page for this record
Discontinued date
10/22/2026
Update type
New
Initial posting date
10/22/2026
Package NDC
0378-6002-91
Generic name
Metformin Hydrochloride Tablet, Extended Release
Contact info
800-796-9526
Related info
A business decision was made was discontinue manufacture of the drug product.
Update date
10/22/2026
Dosage form
Tablet
Presentation
Metformin Hydrochloride, Tablet, Extended Release, 500 mg (NDC 0378-6002-91)
Company name
Mylan Pharmaceuticals Inc., a Viatris Company
Status
To Be Discontinued
Therapeutic category
Endocrinology/Metabolism
Wholesale access for licensed clinicians.

Free to join: your NPI is checked against the federal registry at signup, then wholesale pricing and the professional shelves open.

Join as a DoctorSell on MedGrid

Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.